The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 on oral conditions represents a landmark moment for the community.1 For the first time, a comprehensive analysis of the ...

Shirin Heidari, the Executive Director of GENDRO and Senior Researcher at the Gender Centre, Geneva Graduate Institute in Switzerland, was born in Tehran 6 years before the 1979 Iranian revolution.

The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 ...

At the pace with which the proportion of overweight people is growing, half of Nepal’s adult population will be obese by 2050 ...

A yearly injection to protect against HIV is safe and shows promise as a prevention method with long-lasting effects, according to the results of a c ...

By 2050, over half of adults and a third of children will be overweight or obese globally, with India among the top three ...

Growing prosperity, urbanisation, and sedentary lifestyles are out of sync with Indian cuisine, undoubtedly among the world's ...

Research finds women, younger individuals, and those with nociplastic pain conditions like fibromyalgia are more likely to ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The ...

EUROPE was rocked by fresh measles fears as cases surged to their highest level in over 25 years. Global health officials ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research published in The Lancet medical journal. The drug lenacapavir passed a critical ...